Prevalence and Genotype Distribution of HPV Infection Among People Living With HIV in Colombia
Key facts
- Who runs it
- Hospital Universitario San Ignacio
- Where
- Colombia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 300 people enrolled
- Started
- 11 Mar 2023
- Ended
- 30 Jun 2026
- Type of study
- Observational
- Treatments tested
- Extended High-Risk HPV Genotyping
- Liquid-Based Cytology
- Record updated
- 13 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age 18 years or older, living with HIV
- Attending the HIV clinic of Hospital Universitario San Ignacio
- At least 3 months on antiretroviral therapy
Who cannot take part
- Cognitive or neurological impairment limiting comprehension of the questionnaires
- Active cancer treatment (chemotherapy, radiotherapy or other oncologic therapy)
- Pregnant women with threatened abortion or preterm labor
- Obstructive tumors of the anal canal, cervix or oral cavity
- Contraindication to, or inability to undergo, study procedures, including need for sampling under anesthesia
- Refusal to provide informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
People living with HIV (PLWH) bear a disproportionate burden of human papillomavirus (HPV)-related disease, yet local data across anatomical sites are limited in Colombia and Latin America.
Read full original descriptionShow less
This single-centre cross-sectional study, conducted among adults living with HIV on antiretroviral therapy at the HIV clinic of Hospital Universitario San Ignacio in Bogotá, Colombia, aimed to estimate the prevalence of HPV infection and cytological abnormalities in the anus, cervix and oropharynx; to describe high-risk HPV genotype distribution at each site; and, within the anal component, to explore factors associated with high-risk HPV detection and the agreement between anal cytology and HPV genotyping. Participants were selected by simple random sampling from eligible adults attending the HIV clinic, and liquid-based cytology and extended high-risk HPV genotyping were performed on anal, cervical (when applicable), and oropharyngeal samples.
The group in the trial
- Adults Living With HIV
Adults aged 18 years or older living with HIV and receiving antiretroviral therapy for at least three months at Hospital Universitario San Ignacio in Bogotá, Colombia. Participants were selected through simple random sampling and underwent clinical assessment, liquid-based cytology, and extended high-risk HPV genotyping of anal, cervical (when applicable), and oropharyngeal samples.
Treatment: Extended High-Risk HPV Genotyping and Liquid-Based Cytology
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prevalence, Genotype Distribution, and Clinical Correlates of Human Papillomavirus Infection Among People Living With HIV at Hospital Universitario San Ignacio, Bogotá, Colombia: A Cross-Sectional Study
- Record updated
- 13 November 2026